GUARDIAN PHRMCY SERVICES-A (GRDN) Fundamental Analysis & Valuation

NYSE:GRDN • US40145W1018

Current stock price

35.15 USD
+0.76 (+2.21%)
Last:

This GRDN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. GRDN Profitability Analysis

1.1 Basic Checks

  • In the past year GRDN was profitable.
  • In the past year GRDN had a positive cash flow from operations.
  • Of the past 5 years GRDN 4 years were profitable.
  • In the past 5 years GRDN always reported a positive cash flow from operatings.
GRDN Yearly Net Income VS EBIT VS OCF VS FCFGRDN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • GRDN has a Return On Assets of 11.93%. This is amongst the best in the industry. GRDN outperforms 97.03% of its industry peers.
  • Looking at the Return On Equity, with a value of 23.92%, GRDN belongs to the top of the industry, outperforming 91.09% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 19.24%, GRDN belongs to the best of the industry, outperforming 94.06% of the companies in the same industry.
Industry RankSector Rank
ROA 11.93%
ROE 23.92%
ROIC 19.24%
ROA(3y)-4.52%
ROA(5y)1.44%
ROE(3y)10.51%
ROE(5y)36.52%
ROIC(3y)N/A
ROIC(5y)N/A
GRDN Yearly ROA, ROE, ROICGRDN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 50 -50

1.3 Margins

  • GRDN's Profit Margin of 3.40% is fine compared to the rest of the industry. GRDN outperforms 71.29% of its industry peers.
  • GRDN's Profit Margin has improved in the last couple of years.
  • GRDN has a Operating Margin of 5.02%. This is in the better half of the industry: GRDN outperforms 62.38% of its industry peers.
  • GRDN's Operating Margin has improved in the last couple of years.
  • GRDN's Gross Margin of 20.21% is in line compared to the rest of the industry. GRDN outperforms 44.55% of its industry peers.
  • In the last couple of years the Gross Margin of GRDN has remained more or less at the same level.
Industry RankSector Rank
OM 5.02%
PM (TTM) 3.4%
GM 20.21%
OM growth 3Y-4.27%
OM growth 5Y2.31%
PM growth 3Y-4.47%
PM growth 5Y4.63%
GM growth 3Y-0.4%
GM growth 5Y0.23%
GRDN Yearly Profit, Operating, Gross MarginsGRDN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. GRDN Health Analysis

2.1 Basic Checks

  • GRDN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for GRDN remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for GRDN has been increased compared to 5 years ago.
  • The debt/assets ratio for GRDN has been reduced compared to a year ago.
GRDN Yearly Shares OutstandingGRDN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
GRDN Yearly Total Debt VS Total AssetsGRDN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 10.81 indicates that GRDN is not in any danger for bankruptcy at the moment.
  • GRDN has a better Altman-Z score (10.81) than 96.04% of its industry peers.
  • GRDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.81
ROIC/WACC2.16
WACC8.89%
GRDN Yearly LT Debt VS Equity VS FCFGRDN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.38 indicates that GRDN should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.38, GRDN is in line with its industry, outperforming 51.49% of the companies in the same industry.
  • A Quick Ratio of 1.11 indicates that GRDN should not have too much problems paying its short term obligations.
  • GRDN has a Quick ratio (1.11) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.11
GRDN Yearly Current Assets VS Current LiabilitesGRDN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. GRDN Growth Analysis

3.1 Past

  • GRDN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 142.06%, which is quite impressive.
  • The Earnings Per Share has been growing by 19.43% on average over the past years. This is quite good.
  • The Revenue has grown by 17.93% in the past year. This is quite good.
  • Measured over the past years, GRDN shows a quite strong growth in Revenue. The Revenue has been growing by 14.50% on average per year.
EPS 1Y (TTM)142.06%
EPS 3Y10.91%
EPS 5Y19.43%
EPS Q2Q%73.68%
Revenue 1Y (TTM)17.93%
Revenue growth 3Y16.81%
Revenue growth 5Y14.5%
Sales Q2Q%17.44%

3.2 Future

  • Based on estimates for the next years, GRDN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.71% on average per year.
  • Based on estimates for the next years, GRDN will show a small growth in Revenue. The Revenue will grow by 4.81% on average per year.
EPS Next Y37.1%
EPS Next 2Y24.23%
EPS Next 3Y22.71%
EPS Next 5YN/A
Revenue Next Year-1.77%
Revenue Next 2Y2.59%
Revenue Next 3Y4.81%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GRDN Yearly Revenue VS EstimatesGRDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
GRDN Yearly EPS VS EstimatesGRDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

3

4. GRDN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 45.65, which means the current valuation is very expensive for GRDN.
  • Compared to the rest of the industry, the Price/Earnings ratio of GRDN is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 25.73, GRDN is valued quite expensively.
  • With a Price/Forward Earnings ratio of 33.30, GRDN can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GRDN is on the same level as its industry peers.
  • GRDN's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.72.
Industry RankSector Rank
PE 45.65
Fwd PE 33.3
GRDN Price Earnings VS Forward Price EarningsGRDN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • GRDN's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GRDN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 27.58
EV/EBITDA 22.22
GRDN Per share dataGRDN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • GRDN has a very decent profitability rating, which may justify a higher PE ratio.
  • GRDN's earnings are expected to grow with 22.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.23
PEG (5Y)2.35
EPS Next 2Y24.23%
EPS Next 3Y22.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GRDN Dividend Analysis

5.1 Amount

  • No dividends for GRDN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GRDN Fundamentals: All Metrics, Ratios and Statistics

GUARDIAN PHRMCY SERVICES-A

NYSE:GRDN (3/20/2026, 11:25:10 AM)

35.15

+0.76 (+2.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-11
Earnings (Next)05-11
Inst Owners57.1%
Inst Owner Change-0.95%
Ins Owners8.89%
Ins Owner Change77.34%
Market Cap2.23B
Revenue(TTM)1.45B
Net Income(TTM)49.22M
Analysts86
Price Target35.7 (1.56%)
Short Float %8.14%
Short Ratio7.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.96%
Min EPS beat(2)-13.49%
Max EPS beat(2)29.41%
EPS beat(4)1
Avg EPS beat(4)-3.46%
Min EPS beat(4)-18.3%
Max EPS beat(4)29.41%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.33%
Min Revenue beat(2)0.17%
Max Revenue beat(2)4.48%
Revenue beat(4)4
Avg Revenue beat(4)1.88%
Min Revenue beat(4)0.17%
Max Revenue beat(4)4.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.94%
EPS NY rev (1m)0%
EPS NY rev (3m)3.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 45.65
Fwd PE 33.3
P/S 1.54
P/FCF 27.58
P/OCF 22.2
P/B 10.82
P/tB 20.7
EV/EBITDA 22.22
EPS(TTM)0.77
EY2.19%
EPS(NY)1.06
Fwd EY3%
FCF(TTM)1.27
FCFY3.63%
OCF(TTM)1.58
OCFY4.5%
SpS22.88
BVpS3.25
TBVpS1.7
PEG (NY)1.23
PEG (5Y)2.35
Graham Number7.5
Profitability
Industry RankSector Rank
ROA 11.93%
ROE 23.92%
ROCE 28.85%
ROIC 19.24%
ROICexc 26.02%
ROICexgc 55.01%
OM 5.02%
PM (TTM) 3.4%
GM 20.21%
FCFM 5.57%
ROA(3y)-4.52%
ROA(5y)1.44%
ROE(3y)10.51%
ROE(5y)36.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y6.92%
ROICexgc growth 5Y6.02%
ROICexc growth 3Y3.44%
ROICexc growth 5Y8.17%
OM growth 3Y-4.27%
OM growth 5Y2.31%
PM growth 3Y-4.47%
PM growth 5Y4.63%
GM growth 3Y-0.4%
GM growth 5Y0.23%
F-Score8
Asset Turnover3.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 87.51%
Cap/Sales 1.35%
Interest Coverage 111.85
Cash Conversion 105.49%
Profit Quality 163.98%
Current Ratio 1.38
Quick Ratio 1.11
Altman-Z 10.81
F-Score8
WACC8.89%
ROIC/WACC2.16
Cap/Depr(3y)83.37%
Cap/Depr(5y)81.5%
Cap/Sales(3y)1.36%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)142.06%
EPS 3Y10.91%
EPS 5Y19.43%
EPS Q2Q%73.68%
EPS Next Y37.1%
EPS Next 2Y24.23%
EPS Next 3Y22.71%
EPS Next 5YN/A
Revenue 1Y (TTM)17.93%
Revenue growth 3Y16.81%
Revenue growth 5Y14.5%
Sales Q2Q%17.44%
Revenue Next Year-1.77%
Revenue Next 2Y2.59%
Revenue Next 3Y4.81%
Revenue Next 5YN/A
EBIT growth 1Y215.55%
EBIT growth 3Y11.83%
EBIT growth 5Y17.15%
EBIT Next Year74.38%
EBIT Next 3Y30.11%
EBIT Next 5YN/A
FCF growth 1Y94.05%
FCF growth 3Y36.47%
FCF growth 5Y12.76%
OCF growth 1Y72.97%
OCF growth 3Y27.37%
OCF growth 5Y13.76%

GUARDIAN PHRMCY SERVICES-A / GRDN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GUARDIAN PHRMCY SERVICES-A?

ChartMill assigns a fundamental rating of 6 / 10 to GRDN.


What is the valuation status of GUARDIAN PHRMCY SERVICES-A (GRDN) stock?

ChartMill assigns a valuation rating of 3 / 10 to GUARDIAN PHRMCY SERVICES-A (GRDN). This can be considered as Overvalued.


How profitable is GUARDIAN PHRMCY SERVICES-A (GRDN) stock?

GUARDIAN PHRMCY SERVICES-A (GRDN) has a profitability rating of 7 / 10.


What is the financial health of GUARDIAN PHRMCY SERVICES-A (GRDN) stock?

The financial health rating of GUARDIAN PHRMCY SERVICES-A (GRDN) is 7 / 10.